Background: During recent years, fungal infections have risen exponentially and are a cause of significant morbidity and mortality in hospitalized patients, especially in the critical care setting. There is paucity of data from India on fungal pathogens.
INTRODUCTION
The incidence of fungal infections has risen substantially over the past several decades. Extensive and inappropriate use of antimicrobial agents as well as use of immunosuppressant drugs in various diseases has contributed to the increased propensity for opportunistic fungal infections. 1 An important factor for opportunistic fungal infections is hospitalization of patients, especially in an intensive care unit (ICU). The most common fungi involved in invasive disease in humans are opportunistic yeasts like Candida albicans or filamentous fungi like Aspergillus spp. Fungi such as Candida (except albicans), Fusarium, Trichosporon and Malassezia spp., which were previously considered to be non-pathogenic for humans or were only causing human diseases sporadically are now emerging as leading
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Epidemiology of fungal infections in critical care setting of a tertiary care teaching hospital in North India: a prospective surveillance study nosocomial fungal pathogens. These pathogens are associated with increasing morbidity and mortality. 1, 2 Over past two decades, there has been a change in the distribution of Candida spp. causing nosocomial infections and emerging species are C. tropicalis, C. glabrata, C. parapsilosis, C. krusei, and C. lusitaniae. 2 Candidaemia is frequently a life threatening complication in patients admitted in ICUs. 1 The presence of Candida species in the urine is also common among hospitalized patients. The principal risk factors include antibiotic therapy, urinary catheterization, surgical procedures, female sex and extended hospitalization. 3 Moreover, multiple site colonization with Candida species is also being commonly recognized as a major risk factor for invasive fungal infections in critically ill patients. 4 There is paucity of data from India on fungal infections in the critical care setting with variable results. [5] [6] [7] [8] [9] [10] [11] These studies are mainly from Delhi and there have been sporadic reports fro m Ko lkat a, Pune, Chandigarh and Dehradun. [5] [6] [7] [8] [9] [10] [11] There is an urgent need for surveillance studies on fungal infections and fungal colonizations from different health care institutions nation-wide to provide data on this subject. It is important to differentiate fungal infection from fungal colonizat ion as colonization may precede fungal infection, especially in the critical care setting.
The present study was done in patients with documented fungal infection or fungal colonization admitted in medical and surgical critical care section of a medical college of North India.
MATERIAL AND METHODS
Dayanand Medical College and Hospital (DMCH), Ludhiana, Punjab is a 1000-bed tertiary care institute, providing teaching facilities to undergraduate and postgraduate students including medical and surgical subspecialties. The institute caters to population from Punjab, Haryana, Rajasthan and Himachal Pradesh. The critical care section has 100 beds. The medical critical care section has medical ICU, pulmonary critical care unit and stroke ICU. The surgical critical care section has surgery ICU and neurosurgery ICU.
A prospective surveillance study was performed in the medical and surgical critical care sections at the DMCH, Ludhiana, from January 1 to December 31, 2009 to identify patients with documented fungal infection or fungal colonization. All adult patients above 18 years of age in whom fungal infection or colonization were clinically suspected and confirmed as per inclusion criteria given in Tables 1A and  1B 12-24 respectively were included in the study. The blood sample and body fluids were collected under aseptic conditions in BACTEC culture vials. In CSF sample, minimum of 5 mL was collected in a sterile container. All samples were transported to the laboratory in robust, leak proof sterile containers after putting identification number and name along with requisition slip.
Sample processing
On direct microscopy, samples were examined by preparing either wet mount preparation or potassium hydroxide preparation (depending upon the nature of sample) to study the morphology of fungus. For CSF, India ink preparation and rapid cryptococcal antigen detection test was done.
The samples for fungal culture were inoculated on four tubes of Sabouraud's dextrose agar (SDA). The specimens were inoculated on 4 tubes of SDA (2 with cycloheximide and 2 without cycloheximide) and incubated at 25 O C and 37 O C. SDA was examined daily for first week and twice a week for subsequent 4 weeks. Growth obtained was identified on basis of rate of growth, color, texture, pigmentation and morphological details. Lactophenol cotton blue mount was prepared and seen in 40× magnification on the microscope. Urine samples received for aerobic culture were inoculated on blood agar. The fungus isolated was identified by standard protocols. 25 All isolates of candida from urine and pus were pure or predominant isolates.
Statistical analysis
Baseline continuous variables with normal distribution were compared using unpaired 17, 18 Isolation of Aspergillus species from endotracheal aspirate culture Bronchoalveolar lavage 17, 18 Isolation of Aspergillus species on BAL culture Urine 19, 20 Isolation of Candida species on urine culture with Candiduria > 10 4 colony forming units/ml
Isolation of any type of fungus on pus culture
Fine needle aspiration 22 Isolation of any type of fungus on culture of fine needle aspirates Isolation of Candida species on surgical drain fluid culture t-test; discrete variables were compared using Z-test for proportions. All tests were two-tailed; a p-value less than or equal to 0.05 was considered statistically significant. Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) version 16.
RESULTS
Of the 110 patients enrolled in the study, 91 (82.7%) had fungal infection, whereas 19 (17.3%) had fungal colonization. The mean age of patients with fungal infection and fungal colonization were comparable (Table 2A ; p= 0.1590). The demographic details of patients and critical care section distribution of patients is given in Table 2A . The underlying critical illness among patients with fungal infection admitted in surgical and medical critical care section is given in Table 2B .
The mean ICU stay before the isolation of fungus in the fungal infection and colonization groups were 9.3 (range 1-41) days and 5.1 (range 1-14) days respectively with no statistically significant difference (Table 2A) . The presenting symptoms and clinical signs observed most frequently in patients with fungal infection or fungal colonization are given at Table 3 .
Fungal infections
The most common fungus isolated in patients with fungal infections was Candida (n=85, 93.4%) patients, followed by Aspergillus flavus (3.3%) ( Table 4 ).
The most common specimens yielding fungal infections were urine in (n=68, 74.7%), followed by blood (n=17, 20.8%), BAL fluid (2.2%), sputum endo tracheal aspirat e, cerebrospinal fluid, and pleural fluid (1.1% each). In 2 patients, C. tropicalis was isolated from both blood and urine respectively (Table  5A ). In patients with urinary tract fungal infection, the most common fungus isolated was C. tropicalis (n=45,66.2%), followed by C. albicans (n=17, 25%), non-albicans Candida undifferentiated spp. (4.4%), C. krusei (2.9%) and C. stellatoides (1.5%). Among the patients with blood stream fungal infections, most common fungus isolated was C. tropicalis (n=9,47.4%), followed by C. albicans (n=6, 31.6%), C. guilliermondi (10.5%), C. 
Fungal colonization
The most common fungus isolated from fungal colonization was Candida tropicalis in (n=12, 63%) patients, followed by Candida albicans and Candida stellatoides (15.8 % each, and Candida guilliermondii (5.3%) ( Table 4) . The specimens in patients with fungal colonization were sputum, endotracheal aspirate, BAL fluid (n=6, 31.6% each) and surgical drain fluid (abdomen) (n=1, 5.2%) (Table 5B) .
Critical care setting-related risk factors
In the critical care setting-related risk factors in patients with fungal infections, the most common factor was presence of urinary catheter (85.7%). The other risk factors were central line insertion (81.3%), mechanical ventilation (52.7%), use of corticosteroids (23.1%), total parentral nutrition (6.6%) and peritoneal dialysis (3.3%) ( Table 6 ).
The number of patients with central line insertion (p<0.008) and urinary catheter (p<0.05) were significantly more in fungal infection group whereas, those with peritoneal dialysis (p<0.05) were significantly more in fungal colonization group (Table 6 ). However, there was no significant difference in the mean duration of presence of these risk factors in both the groups.
Among underlying comorbid conditions, diabetes mellitus was present in 28.6% of patients with fungal infection and 26.3% of patients with fungal colonization with no statistically significant difference. Nine patients wit h fungal infections had underlying malignancy ( Table 6 ).
The preference of empirical antibiotics in the critically ill patients was at the discretion of the treating clinician, which was modified in the course of hospitalization depending on bacterial culture sensitivity patterns. The use of antibiotics was present in all patients in fungal infection and fungal colonization groups. The most common antibiotic group used in patients with fungal infections was ureidopenicillins (57.1%), followed by 3 rd generation cephalo -sporins (48.3%), glycopeptides (47.2%), carbapenems (46.1%) The duration o f usage of linco samide (clindamycin) (mean duration 10.8 ± 2.5 days) and macrolide antibiotics (mean duration 7.0 ± 2.8 days) was significantly higher in patients with fungal infections as compared to fungal colonization (p<0.05).
In fungal infections caused by Candida albicans as compared to non-albicans Candida species, there was no statistically significant difference among the mean ICU stay before isolation of fungus, ICU related-risk factors like use of corticosteroids, central line insertion, urinary catheter, respiratory ventilation, peritoneal dialysis, total parentral nutrition and presence of underlying diabetes mellitus or malignancy.
However, there was a statistical trend favouring use of corticosteroids in Candida albicans group (mean duration 13.3 ± 7.5 days) as compared to non-albicans Candida group (mean duration 6.5 ± 5.1 days) (p=0.05). In antibiotics used in both Candida albicans and non-albicans Candida group, uriedopenicillins (58.3% Vs 62.3%) were the commonly used antibiotics, followed by third generation cephalosporins (50% Vs 52.5%), carbapenems (41.7% Vs 52.5%), glycopeptides (50% Vs 50.8%) and nitroimidazole (37.5% Vs 49.2%) respectively with no significant difference between the two groups.
Nevertheless, in the duration of use of antibiotics in the critical care setting, there was a significant difference in the uriedopenicillins with a mean duration of 9.1 ± 3.9 days in Candida albicans group as compared to 6.1 ± 4.6 days in non-albicans Candida group (p<0.05).
DISCUSSION
In this study, the most common fungi isolated in patients with fungal infection admitted in our critical care setting were Candida spp. (93.4%), followed by Aspergillus spp (3.3%). The predominance of Candida spp in nosocomial patients especially in the critical care setting is in consonance with a large multi-centric study done in United States, Canada, South America and Europe as part of international surveillance program for fungal infections. 26, 27 Similarly, the presence of Aspergillus spp. has also been documented as an adjunct cause of fungal infections in critically ill patients in the United States. 28 Among the Candida species, most common fungi isolated in patients with fungal infections (including blood stream as well as urinary tract infections) were non-albicans Candida species (71.7%) in our study. This is also consistent with emergence of predominance of nonalbicans Candida species all over the world. 26, 27 In a study 2 undertaken in United Sates, reported the non-albicans Candida as emerging pathogens as cause of fungaemia. In another study 29 done in Italy, an increase in the nonalbicans Candida species causing blood stream infections in a medical and surgical population has been reported during a 5-year period.
Among the non-albicans Candida species, Candida tropicalis was most common isolate in our study (85.2%). The preponderance of Candida tropicalis is co nsistent with observation in a study from Chandigarh. 30 Similarly, another retrospective study 31 done in Delhi reported C. tropicalis as most common cause of candidaemia. A recent case study 10 on 7 patients has also highlighted the emergence of newer non-albicans Candida like Candida sake in ICU patients. Another study 8 from Dehradun in a relatively smaller patient population has shown contrary results as compared to other centers of our country. 8 This study showed a predominance of Candida albicans in forty one patients. However, there were 13 neonates in the 41 patients enrolled in this study.
In our study, the most common site or specimen of fungus isolation in patients with fungal infection was urine (74.7%) followed by blood (20.8%). C. tropicalis was most common isolate from urine as well as from blood. Similar findings were observed in 2 recent studies of nosocomial urinary tract infection from our country. 7, 10 The age of the patients with fungal infections or fungal colonization in our study ranged from 18 to 86 years; the mean age of patients with fungal infection was 51.2 ± 17.0 years. A study 5 from Delhi reported a similar range of 18 years to 80 years with a mean of 43.5 years. 5 Male predominance was noted in 61.5% patients. The results were consistent with the study 6 done in South India in which male predominance was reported in 71.2% in patients of blood stream Candida infections.
The mean ICU stay before the fungus isolation in patients with fungal infections in our study was found to be 9.3 days (range 1-41 days). In a study 32 from Greece, the mean time from ICU admission to the isolation of Candida from blood specimens was reported to be 9 days (range 5-11 days). In another study 5 from Delhi, the mean stay of 14.9 days with a range of 4-42 days was comparable with our study.
In our study, various ICU related risk factors like use of antiobiotics, urinary catheterization, central line insertion, mechanical ventilation, use of steroids, total parentral nutrition and peritoneal dialysis were compared in fungal infections in relation to fungal colonization. The use of central line insertion and urinary catheter were significantly more in patients with fungal infection as compared to those having fungal colonization. In a study 5 from Delhi, antibiotics, mechanical ventilation and central cathet ers were likewise found to be significantly related to candidaemia. In another study 6 from Kolkata, probable risk factors determined for fungaemia were intensive care unit stay, antibiotic therapy, central line, urinary catheter, ventilator, malignancy and abdominal surgery.
The use of antibiotics was present in all patients with fungal infections and colonization in our study. The most common antibiotic group used in patients wit h fungal infections was uriedopenicillin, followed by third generation cephalosporins, glycopeptides, carbapenems and nitroimidazole. This probably was related to various underlying critical surgical and medical conditions. However, the preference of empirical antibiotics in the critically ill patients was at the discretion of the treating clinician.
In our study, Candida albicans group had no statistically significant difference in the mean ICU stay, ICU-related risk factors like use of steroids, central line insertion, urinary catheter, respiratory ventilation, peritoneal dialysis, total parentral nutrition and presence of underlying diabetes mellitus or malignancy as compared to non-albicans Candida species.
On the other hand, in a study from United States, factors associated with blood stream infections (BSI) due to non-albicans Candida species were compared with Candida albicans BSIs in ICU patients. 33 It was observed that central venous cat heter exposure was associated with increased risk of BSI due to non-albicans Candida species and total parenteral nutrition was associated with a decreased risk of BSIs due to non-albicans Candida species compared with Candida species. However, in supplementary study it was concluded that there are multiple common risk factors for both albicans and non-albicans Candida BSIs and it is not possible to differentiate between these two groups based on clinical characteristics alone. 34 In conclusion, to the best of our knowledge, our study is the largest surveillance study enrolling 110 patients in an adult medical and surgical critical care setting with documented fungal infection and fungal colonization over a period of one year from our country. The emergence of non-albicans Candida similar to the trends in the western countries should be a cause of concern in our country. The major risk factors were use of antibiotics, urinary catheter and central line insertion.
Proper surveillance of fungal pathogens is important to improve quality of care in ICU. There is an urgent need for sensitization of health care personnel to evolve preventive risk factor protocols as part of standard of care to control the surge of fungal infections in critical care settings.
